US FDA approves Moderna’s first mRNA seasonal flu vaccine
The Story in Brief The U.S. Food and Drug Administration has approved Moderna’s mFlusiva seasonal flu vaccine for adults aged 50 and older. It received traditional approval for people aged
All posts tagged in US FDA
1Article
